Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BAY-61-3606
i
Other names:
BAY-61-3606, BAY 61-3606, BAY613606, BAY-613606
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Bayer
Drug class:
SYK inhibitor, NF-κB inhibitor
Related drugs:
‹
GS-9973 (20)
CB-659 (4)
fostamatinib (2)
ALXN2075 (2)
GS-9876 (2)
HM43239 (2)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
SBI-756 (2)
DC-1-192 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
GS-9973 (20)
CB-659 (4)
fostamatinib (2)
ALXN2075 (2)
GS-9876 (2)
HM43239 (2)
EC-70124 (1)
NMS-0963 (0)
PRT062607 (0)
piceatannol (0)
HMPL-523 (0)
SBI-756 (2)
DC-1-192 (1)
sodium metaarsenite (1)
SBI-726 (1)
omtriptolide (1)
CBL0102 (1)
ascorbic acid/menadione (0)
Bay11-7082 (0)
CBL137 IV (0)
antroquinonol (0)
KLTi (0)
SR13668 (0)
efprezimod alfa (0)
bezisterim (0)
iMX-110 (0)
ETS2101 (0)
ACT001 (0)
PBI-05204 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BBOX1 underexpression
Renal Cell Carcinoma
BBOX1 underexpression
Renal Cell Carcinoma
BAY-61-3606
Sensitive: D – Preclinical
BAY-61-3606
Sensitive
:
D
BAY-61-3606
Sensitive: D – Preclinical
BAY-61-3606
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login